DIABETOGENIC INFLUENCE OF HYPERDIET AND CYCLOPHOSPHAMIDE ON THE NON OBESE DIABETIC (NOD) MOUSE.

Authors

  • M.NAJMA HABEEB
  • PRAKASH R. NAIK

Abstract

Objective: The objective of the study is to evaluate the hyper diet and cyclophosphamide accelerated diabetes related metabolic changes in the male NOD mice stock.

Materials and Methods:  Different groups of NOD male mice were fed with hyperdiet and injected intraperitoneally with cyclophosphamide single dose and multiple split doses. Hepatic Hexokinase

Glucose 6 phosphatase, Glucose-6-phosphate dehydrogenase, Glutathione reductase and

Glutathione s Transferase activities were determined.

Results:  Significance differences showed in hyperglycemia in hyperdiet, cyclophosphamide single dose and cyclophosphamide multiple split dose treated animals. Glycosylated hemoglobin showed that there was a significant difference in all the three groups when compared with that of the control group. Whereas, hyperdiet treated and the cyclophosphamide multiple split dose treated animals showed significant similarity. The altered activities of hexokinase, glucose 6 phosphatase, and glucose 6 phosphate dehydrogenase in the liver of NOD male mice resulted in the hyperglycemic state of the treated animals.

 Conclusion: Hyperdiet and cyclophosphamide treated animals showed significant hyperglycemia and also altered few enzyme activity of carbohydrate metabolism. Hence, the non diabetic NOD male mice treated with hyper diet and cyclophosphamide may be a useful model to test therapeutic approaches for amelioration of chronic diabetic complications in humans.

 

 

Key words: NOD mice, Diabetes, Hyperdiet, Cyclophosphamide

Downloads

Download data is not yet available.

References

Koyuturk M, Ozsoy-Sacan O, Bolkent S, Yanardag R. Effect of glurenorm on immunohistochemical changes in pancreatic β -cells of rats in experimental diabetes. Indian J Exp Biol, 2005; 43:268–271.

World Health Organization (a) Fact sheet N°312November 2008 Diabetes mellitus Available at:http://wwwwhoint/mediacentre/factsheets/fs312/en/indexhtml.

Rahman AU, Zaman K. Medicinal plants with hypoglycemic activity. Journal of Ethnopharmacology, 1989; 26: 1-55.

Marles RJ and Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine, 1995; 2: 137.

Jouad H, Haloui M ,Rhiouauani H, El-Hillay J, Edddouks M. Ethnobotanical survey of medicinal plants used for the treatment of diabetes cardiac and renal diseases in the north centre region of Morocco (Fez-Boulemane). Journal of Ethnopharmacology. 2001; 77 175-182.

Rees DA and Alcolado JC. Animal models of diabetes mellitus. Diabet Med, 2005; 22:359–370.

Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest, 1969; 48: 2129–2139.

Lenzen S. The mechanisms of alloxan and streptozotocin-induced diabetes. Diabetologia 2008; 51:216–226.

Delovitch TL and Singh B. The non-obese diabetic mouse as a model of autoimmune diabetes immune dysregulation gets the NOD. Immunity, 1997; 7: 727–738.

Atkinson MA and Leiter EH .The NOD mouse model of type 1 diabetes: as good as it gets? Nature Med, 1999; 5: 601-604.

Makino S ,Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese diabetic strain of mice. Exp Anim, 1980; 29: 1-8.

Eisenbarth GS. Type I diabetes mellitus a chronic autoimmune disease. N Engl J Med 1986; 314:1360–1368.

Douglas L, Coleman Joan E, Kuzava Edward H Leiter. Effect of diet on incidence of diabetes in non obese diabetic mice. Diabetes, 1990; 39.

Pedersen CR, Hagemann I, Bock T, Buschard K. Intermittent feeding and fasting reduces diabetes incidence in BB rats. Autoimmunity, 1999; 30: 243–250.

Oge A, Isganaitis E, Jimenez-Chillaron J, Reamer C, Faucette R, Barry K,Przybyla R, Patti ME. In utero undernutrition reduces diabetes incidence in non-obese diabetic mice. Diabetologia, 2007; 50: 1099–1108.

Fleming RA. An overview of cyclophosphamide and ifosphamide pharmacology. Pharmacotheraphy 1997; 17: 146S-154S.

Like AA, Weringer EJ, Holdash A, McgallP Atkinson D, Rossini AA. Adoptive transfer of autoimmune diabetes mellitus in biobreeding/ worcster (BB/W) inbred and hybred rats. Journal of Immunology, 1985; 134: 1583-1587.

Harada M and Makano S. Promotion of spontaneous diabetes in non obese diabetics prone mice by cyclophosphamide. Diabetologia, 1984; 27: 604-606.

American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr, 1977; 107: 1340-48.

Trinder P. Determination of blood glucose using an oxidase peroxidase system with a non carcinogenic chromogen. J Clin Pathol, 1969; 22:158-161.

Henry. Estimation of urea in blood. J clin chemi, 1974; 5141.

Fossati P and Lorenzo P. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin chem., 1982; 28:2077.

Burstein M,Scholnick H R and Morgin R. rapid method for the isolation of lipoprotein from human serum by precipitation with polyanion. J lipid res, 1970; 11:583.

Willey DG, Roseenthal, M A, Caldwell S. Glycosylated hemoglobin and plasma glycoproteins assay by affinity chromatography. Diabetologia.1984; 27: 56.

Van Der Vies J .Two Methods for the Determination of Glycogen in Liver. Biochem J, 1954; 57:410–6.

Friedweld WT,Levy RI Fedrickson DS. Estimation of concentration of low- density lipoprotein cholesterol in plasm without use of the preparative ultracentrifuge. Clin chem. 1972; 18: 499.

Koida H and Oda T. Pathological occurrence of glucose-6-phosphatase in liver disease. Clin Chem Acta, 1959; 4:554-61.

Fiske CH and Subbarow Y. The colorimetric determination of phosphorous. J Biol Chem, 1925; 66:375–400.

Brandstrup N, Kirk JE, Bruni C. Determination of hexokinase in tissues. J Gerontol, 1957; 12:166-71.

Worthington, CC. Glucose 6 phosphate dehydrogenase.in worthing manual. Worthington biochemical corp., freehold,N.J. ,1988;159-161.

Carlberg I and Mannervik B. Glutathione reductase. Met Enzymol, 1985; 113:484–90.

Habig WJ, Pabst M, Jakoby WB. Glutathione S-transferases, The first enzymatic step in mercapturic acid formation. J Biol Chem, 1974; 249:7130–9.

Elliott RB, Reddy SN, Bibby NJ, Kida K .Dietary prevention of diabetes in the non obese diabetic mouse. Diabetologia, 1988; 31: 62-64.

Sobel DO, Ahvazi B, Jun H S, Chung Y H, Yoon J W. Cyclophosphamide inhibits the development of diabetes in the diabetes prone BB rats. Diabetologia, 2000; 43: 986-994.

Yasunami R and Bach JF. Antisuppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunology, 1988; 18: 481-484.

Khan BA, Abraham A, Leelamma S. Hypoglycemic action of Murray koenigii(curry leaf) Brassica juncea(mustard);mechanism of action. Indian journal of biochemistry and biophysics, 1995; 32: 106-108.

Mitra S K, Gopumadhavan S, Muralidhar T S, Anturlikar S D, Sujatha M B. Effect of D – 400 a herbomineral prepararion on lipid profile glycated haemoglobin and glucose tolerance in streptozocin induced diabetes in rats. Indian journal of experimental biology, 1995;33: 798-800

Furse M, Kimura C, Mabayo RT, Takashi H, Oicumura J. Dietary sorbose prevents and improves hyperglycemia genetically in diabetic mice. Journal of Nutrition, 1993; 123: 59-65.

Mulec H, Blohme G, Grande B, Bjorck S. The effect of metabolic control on rate of decline in renal function in insulin- dependent diabetes mellitus with overt diabetic nephropathy. Nephrol Dial Transplant, 1998;13:651-5.

Ravi K, Sekar DS, Subramanian. Hypoglycemic activity of inorganic constituents in Eugenia jambolana seeds on streptozotocin induced diabetic rats. Biological Trace Element Research 2004; 99:145-155.

Soltani N, Keshavarz M Dehpour AR. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozotocin diabetic rat. Eur. J. Pharmacol, 2007; 560: 201-205.

Jung UJ, Lee MK, Jeong KS, Choi MS. The hypoglycemic effects of hesperidin and narigin are partly mediated by hepatic glucose- regulating enzyme in C57BL/KsJ-db/db. J Nutr 2004; 134: 2499-2503.

Mithievre G, Vidal G, Zitovn C, Miriasian C. Glucose-6-phosphatase mRNA and activity are increased to the same extent in liver and kidney of diabetic rats. Diabetes, 1996; 45: 891–896.

Bopanna KN, Kannan J, Sushma G, Balaraman R. Antidiabetic and antihyperglycemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J Pharmacol, 1997; 29: 162–167.

Iynedjian PB, Gjinovci A, Renold AE. Stimulation by insulin of glucokinase gene transcription in kiver of diabetic rats. J Boil Chem, 1988; 263: 740-744.

Asgary S, Nader GA, Sarraf- Zadegan N, Vakili R. The inhibitory effects of pure flavonoids on in vitro protein glycosylation. J Herb Pharmacother, 2002; 2: 47-55.

Goodarzi M T, Zal F, Malakooti M, Safari M R, Sadeghian S. Inhibitory activity of flavonoids on the lens aldose reductase of healthy and diabetic rats. Acta medica iranica, 2006; 44(1): 41-45.

Goldstein D E, Parker K M, England J D. Clinical applications of glycosylated hemoglobin measurements. Diabetes, 1982; 31: 70-78.

Karunanayake EH, Jeevathayaparan S, Tennekoon KH. Effect of Momordica charantia fruit juice on streptozocin induced diabetes in rats. Journal of Ethnopharmacology 1990; 30: 199-204.

Chen H, Feng R, Guo Y, Sun L, Jiang J. Hypoglycemic effects of aqueous extract of rhizome Polygonati odorati in mice and rats. J Ethnopharmacol, 2001; 74; 225-229.

Koenig R, Peterson CM, Jones RL, Sandek C, Lehrman M, Cerai A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. New England Journal of Medicine, 1976; 295: 417-420.

Baskaran K, Ahmath BK, Shanmugasundaram KR, Shanmugasundaram ERB. Antidiabetic effect of a leaf extract from gymnema sylvestre in non- insulin dependent diabetes mellitus patients. Journal of Ethnopharmacology. 1990; 30: 295-305.

Jackson RL, Hess RL, England J D. Haemoglobin A1c values in children with overt diabetes maintained in varying degree of control. Diabetes Care, 1979; 2: 391-395.

Published

01-10-2013

How to Cite

HABEEB, M., and P. R. NAIK. “DIABETOGENIC INFLUENCE OF HYPERDIET AND CYCLOPHOSPHAMIDE ON THE NON OBESE DIABETIC (NOD) MOUSE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 6, no. 4, Oct. 2013, pp. 138-42, https://journals.innovareacademics.in/index.php/ajpcr/article/view/513.

Issue

Section

Articles